Vimal Mehta, CEO and President at BioXcel Therapeutics, Inc. (BTAI), sold 5,268 shares at $2.62 ($14K) on 2024-04-04, disclosed to the SEC on 2024-04-08.
Scheduled sale ($14k) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.62 | 829 | $2K | 15.7% |
| 2 | $2.62 | 4,439 | $12K | 84.3% |
| Total | $2.62 avg | 5,268 | $14K | 100% |
| Filing → |
| BTAI | SELL | 2024-09-17 | $1K | — | Filing → |
| BTAI | SELL | 2024-06-18 | $3K | — | Filing → |
| BTAI | SELL | 2023-06-16 | $2.5M | — | Filing → |